Alyssa O'keefe, NCC, LPC Counselor - Mental Health Medicare: Medicare Enrolled Practice Location: 175 Wilson Ave, Port Monmouth, NJ 07758 Phone: 551-221-1759 |
Caitlin Moore Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 14 Central Ave, Port Monmouth, NJ 07758 Phone: 908-902-9169 |
Christine Andreotti Bennett, L.P.C. Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 38 Illinois Ave, Port Monmouth, NJ 07758 Phone: 516-695-7299 |
News Archive
LifeSpan BioSciences, Inc., a leading provider of antibodies for thousands of researchers worldwide, has increased the number of validated IHC-plus™ antibodies available in its catalog to more than 3,500. With this increase, LifeSpan is well on its way to building the world's largest catalog of well characterized, IHC-validated reagent antibodies. Overall, LifeSpan has a catalog of more than 82,000 antibodies.
Researchers in the Department of Chemistry at Wake Forest University in collaboration with colleagues at the Wake Forest University Health Sciences Comprehensive Cancer Center have developed a new class of platinum-based anti-tumor drugs that animal studies have shown to be 10 times more effective than current treatments in destroying certain types of lung cancer cells.
Soligenix, Inc., a clinical stage biopharmaceutical company focused on developing products to treat serious inflammatory diseases where there remains an unmet medical need, as well as developing several biodefense vaccines and therapeutics, announced today results demonstrating the improved immunogenicity and rapid action of its anthrax vaccine, VeloThrax™.
Corneal defects often heal themselves, but serious injuries that are left untreated can result in inflammation, infection, ulceration and even blindness.
› Verified 8 days ago